go back

METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION (MECRCN)

METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION (MECRCN)
TANGO2; TANGO2-RELATED METABOLIC ENCEPHALOPATHY AND ARRHYTHMIAS
616878
OMIM = Online Mendelian Inheritance of Men
480864
Transport and Golgi organization protein 2 homolog
22q11.21
very rare (21 cases)
autosomal recessive
mutation in the TANGO2 gene
Laboratory findingsDicarboxylic acids inc (urine)
Ketone bodies (urine) inc (urine)
Tetradecenoylcarnitine (C14:1) normal/inc (blood)
   Glutaric acid normal/inc (urine)
    Adipic acid normal/inc (urine)
    Ammonia inc (blood)
    Creatine kinase inc (serum)
    D-Glucose dec (serum)
    Decenedioic acid normal/inc (urine)
    L-Lactic acid inc (urine)
    L-Lactic acid inc (plasma)
    Myoglobin inc (urine)
    Sebacic acid normal/inc (urine)
    Suberic acid normal/inc (urine)
    Thyroid-stimulating hormone (TSH) inc (serum)
    Transaminases (ASAT/ALAT) inc (serum)
Symptomscardiac arrest
hypothyroidism
lactic acidosis
rhabdomyolysis
  cardiac arrhythmia, dysrhythmia
   cerebral atrophy
   hypertonia, spasticity
   hypoglycemia
   intellectual disability/intellectual developmental disorder
   optic atrophy
   seizures
    ataxia
    cardiomyopathy
    coma
    developmental delay
    dysarthria
    dysphagia
    dystonia
    early death
    encephalopathy
    epilepsy
    gait disturbance
    hearing defect, deafness
    hemiparesis/hemiplegia/hemiparetic cerebral palsy
    hyperammonemia
    ketosis, ketoacidosis
    mental retardation
    microcephaly (<2 SD for age)
    muscle weakness
    neurologic defect or dysfunction
    onset, adolescent
    onset, childhood
    onset, infancy
    paresis
    renal failure, acute/chronic
    strokelike episodes